INTUITIVE SURGICAL INC
ISRG
67 insider filings · Latest: Aug 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2024 | Aug 26 8:03 PM | ROBERT DESANTIS | Proposed Sale | 396 | $486.88 | $192.8K | — | View → |
| Aug 23, 2024 | Aug 23 8:13 PM | HENRY CHARLTON | Proposed Sale | 40,243 | $486.84 | $19.6M | — | View → |
← Previous
Page 9 of 9
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Feb 27 7:36 PM | Gary LoebEVP & Chief Legal and Complian | Option Exercise | 2,442 | $0.00 | 2,746(D) | View → |
| Feb 26, 2026 | Feb 27 7:36 PM | Gary LoebEVP & Chief Legal and Complian | Grant/Award | 4,634 | $0.00 | 3,584(D) | View → |
| Feb 26, 2026 | Feb 27 7:00 PM | Curet MyriamEVP & Chief Medical Officer | Grant/Award | 2,793 | $0.00 | 8,378(D) | View → |
| Feb 26, 2026 | Feb 27 7:00 PM | Curet MyriamEVP & Chief Medical Officer | Option Exercise | 4,654 | $0.00 | 0(D) | View → |
| Feb 26, 2026 | Feb 27 6:52 PM | Fredrik WidmanVP Corporate Controller | Grant/Award | 1,627 | $0.00 | 1,627(D) | View → |
| Feb 26, 2026 | Feb 27 6:52 PM | Fredrik WidmanVP Corporate Controller | Option Exercise | 989 | $0.00 | 1,133(D) | View → |
| Feb 26, 2026 | Feb 27 6:42 PM | David J. RosaDirector, Chief Executive Officer (CEO) | Option Exercise | 6,105 | $0.00 | 6,866(D) | View → |
| Feb 26, 2026 | Feb 27 6:42 PM | David J. RosaDirector, Chief Executive Officer (CEO) | Grant/Award | 21,247 | $0.00 | 13,441(D) | View → |
| Feb 26, 2026 | Feb 27 6:32 PM | Gary S GuthartDirector | Option Exercise | 8,393 | $0.00 | 10,299(D) | View → |
| Feb 26, 2026 | Feb 27 6:32 PM | Gary S GuthartDirector | Grant/Award | 8,778 | $0.00 | 26,334(D) | View → |
| Feb 26, 2026 | Feb 27 6:19 PM | Mark BrosiusSVP & Chief Mfg and Supply Cha | Option Exercise | 2,595 | $0.00 | 2,918(D) | View → |
| Feb 26, 2026 | Feb 27 6:19 PM | Mark BrosiusSVP & Chief Mfg and Supply Cha | Grant/Award | 7,721 | $0.00 | 4,928(D) | View → |
| Feb 10, 2026 | Feb 11 10:37 PM | Curet MyriamEVP & Chief Medical Officer | Option Exercise | 943 | $229.39 | 838(D) | View → |
| Feb 10, 2026 | Feb 11 10:17 PM | Fredrik WidmanVP Corporate Controller | Option Exercise | 567 | $0.00 | 567(D) | View → |
| Feb 10, 2026 | Feb 10 9:28 PM | David J. RosaDirector, Chief Executive Officer (CEO) | Option Exercise | 1,436 | $0.00 | 1,436(D) | View → |
| Feb 10, 2026 | Feb 10 9:18 PM | Gary S GuthartDirector | Option Exercise | 2,633 | $0.00 | 2,633(D) | View → |
| Feb 10, 2026 | Feb 10 8:51 PM | Gary LoebEVP & Chief Legal and Complian | Option Exercise | 315 | $0.00 | 314(D) | View → |
| Feb 10, 2026 | Feb 10 8:26 PM | Iman JeddiSVP & GM da Vinci Platforms & | Option Exercise | 838 | $0.00 | 838(D) | View → |
| Feb 10, 2026 | Feb 10 8:16 PM | Jamie SamathEVP & CFO & Enterprise Technol | Option Exercise | 1,077 | $0.00 | 1,077(D) | View → |
| Feb 10, 2026 | Feb 10 7:16 PM | Henry L CharltonEVP & Chief Commercial and Mkt | Option Exercise | 1,077 | $0.00 | 1,077(D) | View → |